Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients

Pradhan Zia Sultan; Dalvi Rajesla A.; Lai Tze; Kranemann Christoph; Boyd Shelley; Birt Catherine M.

首页> 外文期刊>Canadian journal of ophthalmology >Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients

【24h】

Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients

机译：前列腺素激动剂对青光眼患者基质金属蛋白酶水平的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To determine whether the aqueous levels of matrix metalloproteinases (MMPs) differ between patients with glaucoma treated with topical prostaglandin analogues and normal, nonglaucomatous control patients. Also, to note any difference in MMP levels between latanoprost, travoprost, and bimatoprost that might suggest a difference in efficacy or mechanism of action between these drugs.

机译：目的：确定局部前列腺素类似物治疗的青光眼患者与正常，非青光眼对照患者之间的基质金属蛋白酶（MMPs）水含量是否存在差异。另外，要注意拉坦前列素，曲伏前列素和比马前列素之间的MMP水平存在任何差异，这可能表明这些药物的疗效或作用机理存在差异。

著录项

来源
《Canadian journal of ophthalmology》 |2015年第1期|共5页
作者
Pradhan Zia Sultan; Dalvi Rajesla A.; Lai Tze; Kranemann Christoph; Boyd Shelley; Birt Catherine M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
入库时间 2022-08-18 09:14:54

相似文献

外文文献
中文文献
专利

1. Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients [J] . Pradhan Zia Sultan, Dalvi Rajesla A., Lai Tze, Canadian journal of ophthalmology . 2015,第1期

机译：前列腺素激动剂对青光眼患者基质金属蛋白酶水平的影响
2. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. [J] . Maatta M, Tervahartiala T, Harju M, Journal of glaucoma . 2005,第1期

机译：原发性开角型青光眼，剥脱综合征和剥脱性青光眼患者房水中的基质金属蛋白酶及其组织抑制剂。
3. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. [J] . Schlotzer Schrehardt U, Lommatzsch J, Kuchle M, Investigative ophthalmology & visual science . 2003,第3期

机译：假性剥脱综合征/青光眼和原发性开角型青光眼患者房水中的基质金属蛋白酶及其抑制剂。
4. Serum levels of matrix metalloproteinase-7 evaluation in patients with coronary artery disease [C] . Revnic C.R.Nica A., Craciunescu I., Ioacara S., International Congress on Coronary Artery Disease . 2009

机译：冠状动脉疾病患者的血清基质金属蛋白酶-7评估
5. Cannabinoid receptor 2 agonist reduces immune cell migration in neuroinflammation via inhibition of matrix metalloproteinase-9. [D] . Adhikary, Sabina. 2013

机译：大麻素受体2激动剂通过抑制基质金属蛋白酶9减少神经炎症中的免疫细胞迁移。
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study [O] . Angeline DC Nga, Soon-Lek Yap, Amir Samsudin, 2014

机译：原发性闭角型青光眼患者房水中的基质金属蛋白酶和金属蛋白酶组织抑制剂-定量研究
7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study [O] . Angeline DC Nga, Soon-Lek Yap, Amir Samsudin, 2014

机译：原发性闭角型青光眼患者房水中的基质金属蛋白酶和金属蛋白酶组织抑制剂-定量研究

Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients

摘要

著录项

相似文献

相关主题

期刊订阅